Frequently Asked Questions
In 2022, the market for semen analysis systems was estimated to be worth USD 1024.5 million.
The market for semen analysis systems is anticipated to increase at a CAGR of 4.90% from 2023 to 2030, reaching USD 1502.15 million in 2030.
Computer-assisted semen analysis (CASA) systems are the most popular category of type of semen analysis systems.
Sperm concentration, by the parameters analyzed, is the notable segment.
During the projection period, the fertility clinics category is anticipated to exhibit the highest CAGR.
The semen analysis systems market was ruled by Asia Pacific.
The top players include Lab IVF, MotilityCount ApS, Medical Electronics Systems, Cooper Companies Inc (Cooper Surgical), DNA Diagnostics Center, Inc., Synergy Medical Systems, NW Cryobank, Midland Fertility, Leja Products B.V, Michigan Center for Fertility & women’s Health, Sperm processor, Hamilton Thorne Inc., Bioline Technologies, Arquimea (Arquimea Agrotech), FlowLabs, Androfert, Microptic SL., and others.
Infertility in men is becoming more common, the demand for assisted reproductive technologies is growing, semen analysis services are more readily available, and technology is advancing. These are the factors influencing the expansion of the semen analysis systems market.
The market for semen analysis systems is facing challenges such as low awareness and education, social stigma, expensive semen analysis systems, and rigorous regulatory requirements.
In emerging economies, a variety of prospects for the expansion of the semen analysis systems market exist due to reasons such as technologies for the point-of-care (POC) analysis of sperm, greater demand coming from emerging markets, healthcare prevention, personalized medicine semen analysis is increasing demand. Various market companies are concentrating on growing their market presence in developing countries in order to take advantage of the industry’s growth potential.